Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amen Clinics operates outpatient clinics specializing in the use of brain SPECT imaging combined with comprehensive clinical assessments to diagnose and treat a wide range of mental health conditions. Their approach integrates biological, psychological, social, and spiritual factors. Outcome studies report that approximately 85% of patients experience improved quality of life after treatment at Amen Clinics[2][3].
The company has built one of the world’s largest databases for functional brain scans related to behavior—over 200,000 scans from patients across more than 150 countries[5]. While their methods are innovative within psychiatry—especially their routine use of SPECT—their approach has been met with some skepticism by parts of the mainstream psychiatric community regarding its clinical utility for individualized treatment planning[4].
The company does not develop drugs or biologics but provides personalized mental healthcare using both conventional treatments and non-pharmacological interventions.
No traditional "pipeline" as seen in biotech/pharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amen Clinics.